DTIL
Price
$4.58
Change
-$0.06 (-1.29%)
Updated
May 23 closing price
Capitalization
50.78M
INVA
Price
$18.97
Change
+$0.15 (+0.80%)
Updated
May 23 closing price
Capitalization
1.19B
66 days until earnings call
Interact to see
Advertisement

DTIL vs INVA

Header iconDTIL vs INVA Comparison
Open Charts DTIL vs INVABanner chart's image
Precision BioSciences
Price$4.58
Change-$0.06 (-1.29%)
Volume$29.03K
Capitalization50.78M
Innoviva
Price$18.97
Change+$0.15 (+0.80%)
Volume$808.59K
Capitalization1.19B
DTIL vs INVA Comparison Chart
Loading...
DTIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DTIL vs. INVA commentary
May 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DTIL is a StrongBuy and INVA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
May 25, 2025
Stock price -- (DTIL: $4.58 vs. INVA: $18.97)
Brand notoriety: DTIL and INVA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DTIL: 18% vs. INVA: 103%
Market capitalization -- DTIL: $50.78M vs. INVA: $1.19B
DTIL [@Biotechnology] is valued at $50.78M. INVA’s [@Biotechnology] market capitalization is $1.19B. The market cap for tickers in the [@Biotechnology] industry ranges from $298.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DTIL’s FA Score shows that 0 FA rating(s) are green whileINVA’s FA Score has 1 green FA rating(s).

  • DTIL’s FA Score: 0 green, 5 red.
  • INVA’s FA Score: 1 green, 4 red.
According to our system of comparison, INVA is a better buy in the long-term than DTIL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DTIL’s TA Score shows that 4 TA indicator(s) are bullish while INVA’s TA Score has 6 bullish TA indicator(s).

  • DTIL’s TA Score: 4 bullish, 5 bearish.
  • INVA’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, INVA is a better buy in the short-term than DTIL.

Price Growth

DTIL (@Biotechnology) experienced а -2.76% price change this week, while INVA (@Biotechnology) price change was +2.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.22%. For the same industry, the average monthly price growth was +3.23%, and the average quarterly price growth was -2.73%.

Reported Earning Dates

DTIL is expected to report earnings on Mar 26, 2025.

INVA is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+1.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INVA($1.19B) has a higher market cap than DTIL($50.8M). INVA has higher P/E ratio than DTIL: INVA (51.97) vs DTIL (4.53). DTIL YTD gains are higher at: 20.210 vs. INVA (9.337). DTIL has higher annual earnings (EBITDA): 18.8M vs. INVA (681K). INVA has more cash in the bank: 447M vs. DTIL (101M). DTIL has less debt than INVA: DTIL (30.3M) vs INVA (451M). INVA has higher revenues than DTIL: INVA (370M) vs DTIL (75.1M).
DTILINVADTIL / INVA
Capitalization50.8M1.19B4%
EBITDA18.8M681K2,761%
Gain YTD20.2109.337216%
P/E Ratio4.5351.979%
Revenue75.1M370M20%
Total Cash101M447M23%
Total Debt30.3M451M7%
FUNDAMENTALS RATINGS
DTIL vs INVA: Fundamental Ratings
DTIL
INVA
OUTLOOK RATING
1..100
7222
VALUATION
overvalued / fair valued / undervalued
1..100
34
Fair valued
75
Overvalued
PROFIT vs RISK RATING
1..100
10059
SMR RATING
1..100
4091
PRICE GROWTH RATING
1..100
9049
P/E GROWTH RATING
1..100
1002
SEASONALITY SCORE
1..100
4648

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DTIL's Valuation (34) in the Biotechnology industry is somewhat better than the same rating for INVA (75) in the Pharmaceuticals Other industry. This means that DTIL’s stock grew somewhat faster than INVA’s over the last 12 months.

INVA's Profit vs Risk Rating (59) in the Pharmaceuticals Other industry is somewhat better than the same rating for DTIL (100) in the Biotechnology industry. This means that INVA’s stock grew somewhat faster than DTIL’s over the last 12 months.

DTIL's SMR Rating (40) in the Biotechnology industry is somewhat better than the same rating for INVA (91) in the Pharmaceuticals Other industry. This means that DTIL’s stock grew somewhat faster than INVA’s over the last 12 months.

INVA's Price Growth Rating (49) in the Pharmaceuticals Other industry is somewhat better than the same rating for DTIL (90) in the Biotechnology industry. This means that INVA’s stock grew somewhat faster than DTIL’s over the last 12 months.

INVA's P/E Growth Rating (2) in the Pharmaceuticals Other industry is significantly better than the same rating for DTIL (100) in the Biotechnology industry. This means that INVA’s stock grew significantly faster than DTIL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DTILINVA
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
68%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
60%
MACD
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
72%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
62%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
64%
Advances
ODDS (%)
Bullish Trend 24 days ago
79%
Bullish Trend 5 days ago
67%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 12 days ago
64%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
81%
Aroon
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
68%
View a ticker or compare two or three
Interact to see
Advertisement
DTIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SWASX6.400.02
+0.31%
Schwab Global Real Estate
RGLGX25.15-0.04
-0.16%
American Funds Global Insight R-6
WBSNX25.71-0.09
-0.35%
William Blair Small Cap Growth N
STFBX86.92-0.39
-0.45%
State Farm Balanced
APHNX16.45-0.08
-0.48%
Artisan Select Equity Institutional

DTIL and

Correlation & Price change

A.I.dvisor indicates that over the last year, DTIL has been loosely correlated with AXON. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if DTIL jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DTIL
1D Price
Change %
DTIL100%
-1.29%
AXON - DTIL
46%
Loosely correlated
-0.55%
ORMP - DTIL
41%
Loosely correlated
+0.47%
ARRY - DTIL
39%
Loosely correlated
-3.23%
RENB - DTIL
36%
Loosely correlated
-1.98%
GLYC - DTIL
35%
Loosely correlated
-1.61%
More

INVA and

Correlation & Price change

A.I.dvisor indicates that over the last year, INVA has been loosely correlated with SGMO. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if INVA jumps, then SGMO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INVA
1D Price
Change %
INVA100%
+0.80%
SGMO - INVA
40%
Loosely correlated
-5.34%
CLDX - INVA
38%
Loosely correlated
+2.01%
LGND - INVA
35%
Loosely correlated
-0.83%
DNLI - INVA
35%
Loosely correlated
-1.76%
HALO - INVA
34%
Loosely correlated
+1.47%
More